Table 2 Correlations between the baseline characteristics and pathological findings.
eGFR, ml/min/1.73 m2 | Urinary protein†, g/day or g/gCr | Haematuria* | Anti-dsDNA antibody level††, IU/ml | Serum C3 level, mg/dl | |
|---|---|---|---|---|---|
Activity index | − 0.40 | 0.36 | 0.40 | 0.35 | − 0.21 |
Endocapillary hypercellularity | − 0.09 | 0.37 | 0.33 | 0.30 | − 0.43 |
Neutrophils/karyorrhexis | − 0.06 | 0.21 | 0.33 | 0.28 | − 0.20 |
Hyaline deposits | − 0.17 | 0.19 | 0.26 | 0.32 | − 0.31 |
Fibrinoid necrosis | − 0.03 | 0.07 | 0.06 | 0.16 | − 0.04 |
Cellular/fibrocellular crescents | − 0.34 | 0.24 | 0.27 | 0.19 | − 0.03 |
Interstitial Inflammation | − 0.55 | 0.15 | 0.14 | 0.05 | 0.13 |
Chronicity index | − 0.52 | 0.11 | 0.07 | 0.05 | 0.19 |
Global/segmental sclerosis | − 0.26 | − 0.02 | 0.00 | − 0.05 | 0.17 |
Fibrous crescents | − 0.06 | − 0.06 | − 0.06 | 0.07 | 0.07 |
Interstitial fibrosis | − 0.56 | 0.17 | 0.10 | 0.05 | 0.18 |
Tubular atrophy | − 0.53 | 0.13 | 0.08 | 0.06 | 0.16 |